PATJ and nonpapillary renal cell carcinoma: A previous study reported a PATJ somatic mutation in two of the three PD-L1-positive ccRCC cases (Wang et al., 2018); thus, suggesting that PATJ might be a promising predictive factor for PD-L1 expression in ccRCC cells.